Study Stopped
no open study
Clinical Echography in Emergency Prognostic Evaluation of Pulmonary Embolism: ECU -EP Study.
ECU-EP
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
Pulmonary Embolism (PE) is a frequent disease, the third cause of cardiovascular death after stroke and myocardial infarction. According to European guidelines of European Society of Cardiology (ESC) and of European Respiratory Society (ERS), the prognostic stratification of PE severity is mandatory as soon as PE is diagnosed. This stratification includes the hemodynamic status, and specific tools : the assessment of the sPESI score, and the evaluation of PE's impact on right ventricle (RV) : increased biomarkers (troponin, BNP) and right ventricle/left ventricle (RV/LV) ratio. the RV/LV ration may be evaluated ideally by transthoracic echo (TTE), or by CT scan. Unfortunately, only 10% of patients with PE are evaluated with TTE by a cardiologist in the initial time of PE diagnosis. Hence, the CT scan is the most frequent way to assess RV/LV ratio. However, CT is not possible for all patients (patients with contra-indication) or may have difficulties to provide a clear assessment because of technical issues. Then, there is a need for morphological evaluation of RV as soon as PE is diagnosed, in every clinical setting. The improvement in technologies allowed the development of clinical echography (CE) in emergency departments. CE is already available, non-invasive, less expansive, and may be a good way to assess RV/LV ratio in patients with PE diagnosed in emergency departments. The investigators propose a prospective, multicenter study to assess the sensitivity of CE in patients with PE, compared to CT scan to detect RV/LV ≥0.9.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2018
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2017
CompletedFirst Posted
Study publicly available on registry
December 8, 2017
CompletedStudy Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedApril 4, 2019
March 1, 2019
1 month
November 21, 2017
April 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients with a measure RV/LV ratio ≥ 0.9 on clinical echography (CE) and CT Scan
Sensitivity of clinical echography (CE) to CT Scan to detect an increased RV/LV ratio above 0.9.
day 1
Secondary Outcomes (3)
Patients with a measure RV/LV ratio < 0.9 on clinical echography (CE) and CT Scan
day 1
Patients with abnormal inferior vena cava.
day 30
death
day 30
Study Arms (1)
patients with pulmonary embolism
patients with pulmonary embolism confirmed by tomography scan in emergency department
Interventions
clinical echography (CE) is performed in the first 24 hours following the diagnosis of PE, in emergency unit
Eligibility Criteria
All patients with a PE confirmed in emergency unit
You may qualify if:
- Adult patients with pulmonary embolism confirmed
- Simplified Pulmonary Embolism Severity Index (sPESI) ≥ 1
You may not qualify if:
- Contra-indication to CT scanner
- Patients with high-risk pulmonary embolism (shock, hypotension)
- Simplified Pulmonary Embolism Severity Index (sPESI) =0
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alain Viallon, MD PhD
Centre Hospitalier Universitaire de Saint Etienne
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 21, 2017
First Posted
December 8, 2017
Study Start
November 1, 2018
Primary Completion
December 1, 2018
Study Completion
January 1, 2019
Last Updated
April 4, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share